Harman Finochem Ltd has emerged as a major player and has earned reputation as a leading manufacturer of active pharmaceutical ingredient (APIs) in India since past 33 years . It supplies APIs to many leading generic and multinational pharmaceutical companies for their finished dosages in Europe, USA, Japan, Australia, Middle East, North Africa, Asia, Saarc, CIS and Latam.
Harman’s two state of the art facilities at Aurangabad, have been inspected and accepted by most of the regulatory bodies like WHO-GMP, USFDA, EU-GMP, TGA - Australia, Health Canada, KFDA, Cofepris with the acceptance of manufacturing site as GMP compliant.
Harman is a front runner manufacturing 45 APIs including controlled substances and WHO’s essential medicines having dedicated powder processing areas for most of their products with current annual production capacities of 20617 metric tonnes with advance innovative packaging and multiple packaging options etc.
Soon Harman will be world’s largest manufacturer for its key product Metformin HCl with largest batch size of 6000 Kg. A new dedicated plant will be ready soon. A new R & D centre will be ready to empower more people in next financial year, with a total built up area of 77000 sq.ft. having labs for custom/ contract research and development. OSD facility will be ready to cater customer’s requirement of Direct Compression (DC) granules, bulk tablets and tablets packed in blisters, bottles etc.
Harman holds a vision to convert the company to a CMO. Customers will be served complete solutions starting with chemical development to commercial API manufacturing and ending with formulation development to finished dosage pharmaceutical production.
For more details visit
www.harmanfinochem.com, www.metforminapi.in, www.allopurinolapi.in